|Up a level|
Górriz , J. M. and Puntonet, Carlos G. and Rojas, F. and Martin, R. and Hornillo, S. and Lang, Elmar (2006) Optimizing blind source separation with guided genetic algorithms. Neurocomputing 69 (13-15), pp. 1442-1457.
Martin, R. and Schwuléra, U. and Menke, G. and Rudolph, W. and Buch, K. and Fasold, H. and Lissner, R. and Thrun, A. and Krauseneck, P. and Bogdahn, U. (1992) Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration. European cytokine network 3 (4), pp. 399-406.
Schäfer, E. and Dummer, R. and Eilles, Christoph and Börner, W. and Martin, R. and Rendl, J. and Burg, G. (1991) Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma. European journal of nuclear medicine 18 (2), pp. 106-110.
Weilbach, F. X. and Bogdahn, U. and Poot, M. and Apfel, R. and Behl, C. and Drenkard, D. and Martin, R. and Hoehn, H. (1990) Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment. Cancer research 50 (21), pp. 6981-6986.
Bogdahn, U. and Apfel, R. and Hahn, M. and Gerlach, M. and Behl, C. and Hoppe, J. and Martin, R. (1989) Autocrine tumor cell growth-inhibiting activities from human malignant melanoma. Cancer research 49 (19), pp. 5358-5363.
Bogdahn, U. and Zapf, J. and Weber, H. and Dünisch, G. and Löbering, H. G. and Martin, R. and Mertens, H. G. (1987) Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours. British journal of cancer 55 (2), pp. 153-158.